Interferon-α plus lamivudinevslamivudine reduces breakthroughs, but does not affect sustained response in HBeAg negative chronic hepatitis B

Συγγραφείς: Economou, Michalis, Manolakopoulos, Spilios, Trikalinos, Thomas A., Filis, Spyros, Bethanis, Sotiris, Tzourmakliotis, Dimitrios, Avgerinos, Alec, Raptis, Sotiris, Tsianos, Epameinondas V.

Πηγή: World Journal of Gastroenterology. 11:5882

Θεματικοί όροι: Adult, Male, Hepatitis B, Chronic/*drug therapy/genetics, Genotype, Hepatitis B e Antigens/*immunology, Drug Therapy, Combination, Antiviral Agents, 12. Responsible consumption, 03 medical and health sciences, Hepatitis B, Chronic, 0302 clinical medicine, Humans, Hepatitis B e Antigens, Alanine Transaminase/blood, Reverse Transcriptase Inhibitors/metabolism/*therapeutic use, Aged, Antiviral Agents/metabolism/*therapeutic use, Interferon-alpha/adverse effects/metabolism/*therapeutic use, Interferon-alpha, Alanine Transaminase, Middle Aged, Lamivudine/metabolism/*therapeutic use, 3. Good health, Treatment Outcome, Lamivudine, DNA, Viral, DNA, Viral/blood, Reverse Transcriptase Inhibitors

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/16270403
https://www.wjgnet.com/1007-9327/full/v11/i37/5882.htm
http://europepmc.org/articles/PMC4479694
https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZXXY200537024.htm
https://www.ncbi.nlm.nih.gov/pubmed/16270403
http://olympias.lib.uoi.gr/jspui/handle/123456789/20708
https://pergamos.lib.uoa.gr/uoa/dl/object/3097547

Interferon-alpha plus lamivudine vs lamivudine reduces breakthroughs, but does not affect sustained response in HBeAg negative chronic hepatitis B

Συγγραφείς: Economou, M., Manolakopoulos, S., Trikalinos, T. A., Filis, S., Bethanis, S., Tzourmakliotis, D., Avgerinos, A., Raptis, S., Tsianos, E. V.

Θεματικοί όροι: Adult, Aged, Alanine Transaminase/blood, Antiviral Agents/metabolism/*therapeutic use, DNA, Viral/blood, Drug Therapy, Combination, Genotype, Hepatitis B e Antigens/*immunology, Hepatitis B, Chronic/*drug therapy/genetics, Humans, Interferon-alpha/adverse effects/metabolism/*therapeutic use, Lamivudine/metabolism/*therapeutic use, Male, Middle Aged, Reverse Transcriptase Inhibitors/metabolism/*therapeutic use, Treatment Outcome

Relation: http://olympias.lib.uoi.gr/jspui/handle/123456789/20708

Διαθεσιμότητα: http://olympias.lib.uoi.gr/jspui/handle/123456789/20708

Role of the K65R, L74V, and M184V mutations within HIV-1 reverse transcriptase in drug resistance and viral replication

Συγγραφείς: Frankel, Fernando A.

Θεματικοί όροι: Anti-HIV Agents -- metabolism, Drug Resistance, Viral, HIV-1 -- drug effects, HIV-1 Reverse Transcriptase -- metabolism, Reverse Transcriptase Inhibitors -- metabolism

Relation: Proquest: AAINR50818; Pid: 113862; https://escholarship.mcgill.ca/concern/theses/s4655m085

Διαθεσιμότητα: https://escholarship.mcgill.ca/concern/theses/s4655m085